Scientific and technical disclosures in this news release have been reviewed and approved by Mr. Gavin Berkenheger, who is considered, by virtue of his education, experience, and professional ...

Novel next-generation Bruton tyrosine kinase (BTK)-targeted protein degrader APG-3288 has received investigational new drug ...

After a lengthy downturn, the biotech industry finally gathered momentum in 2025. Key readouts in obesity, infectious disease ...

The programs are an outgrowth of the awareness of the importance of the first 3 years in a child’s intellectual, emotional ...

V listed Electrum Discovery Corp to create a well-funded gold and copper explorer with a strong portfolio of advanced ...

Metformin, a common type 2 diabetes medication, is being investigated for its potential anti-cancer effects. Research ...

Who knows? Cooking on Wheels may turn into more of a business selling adaptive cookware. The entrepreneurship possibilities ...

Most people, especially New Yorkers, who are proud of their tap water, mock my interest in mineral water; to them, “all water ...

Aging is inevitable as death and taxes but the rate we change varies a lot between individuals," Dr. Kuchel said.

Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of programs that target novel mechanisms of action for a broad range of ...

“This expansion reflects our confidence in Nigeria's future, our belief in Africa's potential, and our commitment to building ...

Dynavax's adult hepatitis B vaccine HEPLISAV-B is currently marketed in the US and is differentiated by its two-dose regimen over one month, which enables high levels of seroprotection faster than ...